Page last updated: 2024-08-22

sodium arsenite and Electrocardiogram QT Prolonged

sodium arsenite has been researched along with Electrocardiogram QT Prolonged in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, KL; Lin, YC; Phan, NN1
Beumer, JH; Edelman, MJ; Feliciano, J; Gobbru, J; Lapidus, R; Liu, T; Styblo, M1

Trials

1 trial(s) available for sodium arsenite and Electrocardiogram QT Prolonged

ArticleYear
Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors.
    Cancer chemotherapy and pharmacology, 2016, Volume: 78, Issue:5

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic; Arsenites; Cisplatin; Endpoint Determination; Enzyme Inhibitors; Female; Humans; Long QT Syndrome; Male; Middle Aged; Neoplasms; Platinum; Sodium Compounds; Telomerase; Treatment Outcome

2016

Other Studies

1 other study(ies) available for sodium arsenite and Electrocardiogram QT Prolonged

ArticleYear
Arsenic induces cardiac rhythm dysfunction and acylcarnitines metabolism perturbation in rats.
    Toxicology mechanisms and methods, 2018, Volume: 28, Issue:6

    Topics: Animals; Arsenites; Carnitine; Dose-Response Relationship, Drug; Electrocardiography; Environmental Pollutants; Heart Rate; Long QT Syndrome; Male; Rats, Sprague-Dawley; Sodium Compounds

2018